Back to companies

Loxo Oncology Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Loxo Oncology Inc (Loxo Oncology) a biopharmaceutical company that carries out the development of targeted small molecule therapeutics for the treatment of cancer. The company's pipeline products include FGFR3 SELECTIVE, PI3Kα INIBITOR, 225Ac-PSMA-62 PNT2001, 225Ac-PSMA-62 PNT2001, NECTIN-4 ADC 1 are for the treatment of cancer; OLOMORASIB: KRAS G12C treats mutant non small cell lung cancer (NSCLC); ABEMACICLIB targets metastatic breast cancer (MBC) sequencing; SELPERCATINIB treats adjuvant RET+ non small cell lung cancer (NSCLC); IMLUNESTRANT for ER+ HER2 metastatic breast cancer (mBC) and adjuvant breast cancer; PIRTOBRUTINIB for relapsed/refractory chronic lymphocytic leukemia (CLL) combination, 1L chronic lymphocytic leukemia (CLL) monotherapy. Loxo Oncology is headquartered in Stamford, Connecticut, the US.

 Gain a 360-degree view of Loxo Oncology Inc and make more informed decisions for your business Gain a 360-degree view of Loxo Oncology Inc and make more informed decisions for your business Register your interest
Headquarters United States of America
Address 9th Floor, 281 Tresser Blvd, Stamford, Connecticut, 06901
Website www.loxooncology.com
Telephone 1 203 6533880
Industry Pharmaceuticals and Healthcare
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Loxo Oncology Inc premium industry data and analytics

70+

Catalyst Calendar

Proactively evaluate Loxo Oncology Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

70+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Loxo Oncology Inc’s relevant decision makers and contact details.

50+

Clinical Trials

Determine Loxo Oncology Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

19+

Pipeline Drugs

Identify which of Loxo Oncology Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

18+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

3

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Products and Services

Products
Pipeline
FGFR3 SELECTIVE: Cancer
PI3Kα INIBITOR: Cancer
XYZ
XYZ
XYZ
Understand Loxo Oncology Inc portfolio and identify potential areas for collaboration Understand Loxo Oncology Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Loxo Oncology Inc Amgen Inc Repare Therapeutics Inc Ariad Pharmaceuticals Inc ArQule Inc
Headquarters United States of America United States of America Canada United States of America United States of America
City Stamford Thousand Oaks St. Laurent Cambridge Rahway
State/Province Connecticut California Quebec Massachusetts New Jersey
No. of Employees - 31,500 129 - -
Entity Type Private Public Private Private Private
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Executives
Name Position Board Since Age
Karsten Boehnke Principal Research Scientist Senior Management - -
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Loxo Oncology Inc key executives to enhance your sales strategy Gain insight into Loxo Oncology Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?